This Article Full Text Full Text (PDF) All Versions of this Article: 109/1/92    most recent 01.CIR.0000108925.95658.8Dv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yanai, H. Articles by Strott, C. A. Search for Related Content PubMed PubMed Citation Articles by Yanai, H. Articles by Strott, C. A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM UniGene Compound via MeSH Substance via MeSH Related Collections Aggregation Lipid and lipoprotein metabolism Platelets

(Circulation. 2004;109:92-96.)
© 2004 American Heart Association, Inc.

Basic Science Reports

Expression of Cholesterol Sulfotransferase (SULT2B1b) in Human Platelets

From the Section on Steroid Regulation, Endocrinology, and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md.

Correspondence to Charles A. Strott, MD, National Institutes of Health, Building 49, Room 6A36, Bethesda, MD 20892-4510. E-mail chastro{at}mail.nih.gov

Received March 26, 2003; de novo received August 4, 2003; revision received September 3, 2003; accepted September 8, 2003.

Background— Cholesterol sulfate, the most important sterol sulfate in the human circulation, has emerged as a multifaceted molecule. Among its many demonstrated regulatory actions is its ability to influence blood clotting and fibrinolysis. Additionally, cholesterol sulfate is a constituent of human platelets, where it has been shown to support platelet aggregation.

Methods and Results— We have documented the presence of the enzyme (SULT2B1b) that sulfonates cholesterol in human platelets and examined the influence of plasma lipoproteins on the expression and activity of this enzyme. SULT2B1b mRNA was detected by reverse transcription-polymerase chain reaction and found to be the only steroid/sterol sulfotransferase expressed in these discoid anucleate particles. Using real-time polymerase chain reaction for quantification, we found that the level of SULT2B1b mRNA in platelets was maintained at 4°C but substantially diminished over a period of 4 hours at 37°C. The loss of SULT2B1b mRNA, however, was markedly reduced in the presence of HDL but not LDL. The stabilizing influence of HDL was attributable specifically to its apolipoprotein (apo) A-I component, whereas apoA-II and apoE were without effect. Importantly, there was a direct correlation between platelet SULT2B1b mRNA and protein levels in the presence or absence of lipoprotein that was reflected in enzymatic activity and cholesterol sulfate production.

Conclusions— Human platelets selectively express SULT2B1b, the physiological cholesterol sulfotransferase. Furthermore, the stability of SULT2B1b mRNA and protein in platelets maintained at 37°C is subject to regulation by the apoA-I component of HDL.

Key Words: platelets • lipoproteins • apolipoproteins • cholesterol

This article has been cited by other articles:

				Y. Ji, I. Moon, J. Zlatkovic, O. E. Salavaggione, B. A. Thomae, B. W. Eckloff, E. D. Wieben, D. J. Schaid, and R. M. Weinshilboum Human Hydroxysteroid Sulfotransferase SULT2B1 Pharmacogenomics: Gene Sequence Variation and Functional Genomics J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 529 - 540. [Abstract] [Full Text] [PDF]